Eagle Pharmaceuticals, Inc.

EGRX · OTC
Analyze with AI
Key StatsIncome StatementBalance SheetCash Flow
AnnualQuarterly
KMB
3/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets––––
Cash & Equivalents–$55,321$97,659$103,155
Short-Term Investments–$0$0$0
Receivables–$73,440$41,496$51,117
Inventory–$47,794$21,908$8,075
Other Curr. Assets–$12,199$11,543$3,718
Total Curr. Assets–$188,754$172,606$166,065
Property Plant & Equip (Net)–$1,168$1,636$2,077
Goodwill–$45,033$39,743$39,743
Intangibles–$118,327$10,671$12,917
Long-Term Investments–$10,011$0$12,200
Tax Assets–$27,146$18,798$15,180
Other NC Assets–$15,721$10,278$5,008
Total NC Assets–$217,406$81,126$87,125
Other Assets–$0$0$0
Total Assets–$406,160$253,732$253,190
Liabilities––––
Payables–$18,993$16,431$6,268
Short-Term Debt–$7,784$26,916$9,123
Tax Payable–$5,182$0$0
Deferred Revenue–$0$25,363$0
Other Curr. Liab.–$79,128$5,666$22,694
Total Curr. Liab.–$111,087$74,376$38,085
LT Debt–$60,005$2,904$29,094
Deferred Rev, NC–$0-$1,751-$5,892
Deferred Tax Liab, NC–$0$1,751$1,933
Other NC Liab.–$3,789-$1$3,959
Total NC Liab.–$61,513$2,903$29,094
Other Liabilities–$0$0$0
Cap. Leases–$5,323$4,213$5,082
Total Liabilities–$172,600$77,279$67,179
Equity––––
Pref Stock–$0$0$0
Common Stock–$18$17$17
Retained Earnings–$111,504$75,862$84,489
AOCI–-$1,112-$94$0
Other Equity–$123,150$100,668$101,505
Total Equity–$233,560$176,453$186,011
Supplemental Information––––
Minority Interest–$0$0$0
Total Liab. & Tot. Equity–$406,160$253,732$253,190
Net Debt$0$12,468-$67,839-$64,938